| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RS domain binding | 4.81e-07 | 8 | 42 | 3 | GO:0050733 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 1.41e-06 | 11 | 42 | 3 | GO:0099122 | |
| GeneOntologyMolecularFunction | mRNA binding | 1.12e-05 | 694 | 42 | 9 | GO:0003729 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 4.30e-05 | 5 | 42 | 2 | GO:1990269 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 7.50e-05 | 39 | 42 | 3 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 1.15e-04 | 45 | 42 | 3 | GO:0043175 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 2.81e-04 | 12 | 42 | 2 | GO:0050815 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 3.45e-04 | 65 | 42 | 3 | GO:0070063 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 3.61e-04 | 66 | 42 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 3.61e-04 | 66 | 42 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 4.40e-03 | 47 | 42 | 2 | GO:0004712 | |
| GeneOntologyBiologicalProcess | RNA splicing | DDX23 ACIN1 SNRNP27 SRRM1 SCAF1 RSRP1 LUC7L CACTIN SRSF11 PRPF38B PPIG PRPF38A SREK1 SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 RNPS1 CLK2 CDK13 CLK3 SRSF8 SRRM4 RSRC1 CCNL1 SON DHX8 ZRANB2 | 1.25e-41 | 502 | 42 | 31 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA processing | DDX23 ACIN1 SNRNP27 SRRM1 SCAF1 RSRP1 LUC7L CACTIN SRSF11 PRPF38B PRPF38A SREK1 SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 RNPS1 SCAF8 CDK13 SRSF8 SRRM4 RSRC1 SCAF4 SON DHX8 ZRANB2 | 2.11e-36 | 551 | 42 | 29 | GO:0006397 |
| GeneOntologyBiologicalProcess | RNA processing | DDX23 ACIN1 SNRNP27 SRRM1 SCAF1 RSRP1 LUC7L CACTIN SRSF11 PRPF38B PPIG PRPF38A SREK1 SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 RNPS1 SCAF8 CLK2 CDK13 CLK3 SRSF8 SRRM4 RSRC1 SCAF4 CCNL1 SON DHX8 ZRANB2 | 4.59e-30 | 1500 | 42 | 33 | GO:0006396 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | DDX23 ACIN1 SNRNP27 SRRM1 SCAF1 RSRP1 LUC7L CACTIN SRSF11 PRPF38B PRPF38A SREK1 SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 RNPS1 SCAF8 CDK13 SRSF8 SRRM4 RSRC1 SCAF4 SON DHX8 ZRANB2 | 5.91e-30 | 917 | 42 | 29 | GO:0016071 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | DDX23 ACIN1 SNRNP27 SRRM1 RSRP1 LUC7L CACTIN PRPF38A SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 SRRM2 RNPS1 CDK13 SRSF8 SRRM4 RSRC1 SON DHX8 | 2.30e-26 | 358 | 42 | 21 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | DDX23 ACIN1 SNRNP27 SRRM1 RSRP1 LUC7L CACTIN PRPF38A SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 SRRM2 RNPS1 CDK13 SRSF8 SRRM4 RSRC1 SON DHX8 | 2.30e-26 | 358 | 42 | 21 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | DDX23 ACIN1 SNRNP27 SRRM1 RSRP1 LUC7L CACTIN PRPF38A SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 SRRM2 RNPS1 CDK13 SRSF8 SRRM4 RSRC1 SON DHX8 | 2.91e-26 | 362 | 42 | 21 | GO:0000375 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | ACIN1 SRRM1 SRSF2 SRSF5 SRSF6 SFSWAP AKAP17A RNPS1 CLK2 CLK3 SRRM4 CCNL1 SON | 1.42e-16 | 207 | 42 | 13 | GO:0043484 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.86e-10 | 129 | 42 | 8 | GO:0048024 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 2.23e-10 | 79 | 42 | 7 | GO:0000380 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 9.39e-10 | 158 | 42 | 8 | GO:0050684 | |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 1.11e-09 | 99 | 42 | 7 | GO:0000245 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 3.89e-08 | 254 | 42 | 8 | GO:0071826 | |
| GeneOntologyBiologicalProcess | mRNA splice site recognition | 6.63e-08 | 52 | 42 | 5 | GO:0006376 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 2.93e-07 | 28 | 42 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 3.40e-07 | 29 | 42 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 5.64e-07 | 244 | 42 | 7 | GO:0022618 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 5.82e-07 | 33 | 42 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 2.64e-06 | 443 | 42 | 8 | GO:1903311 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 4.05e-06 | 2 | 42 | 2 | GO:2000805 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription | 4.05e-06 | 2 | 42 | 2 | GO:0120191 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 6.23e-06 | 59 | 42 | 4 | GO:0000381 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 1.21e-05 | 3 | 42 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription, poly(A)-coupled | 1.21e-05 | 3 | 42 | 2 | GO:0030846 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 1.21e-05 | 3 | 42 | 2 | GO:2000804 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 2.42e-05 | 4 | 42 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 6.04e-05 | 6 | 42 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 7.34e-05 | 515 | 42 | 7 | GO:0022613 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 8.72e-05 | 115 | 42 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | mRNA cis splicing, via spliceosome | 1.20e-04 | 47 | 42 | 3 | GO:0045292 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription | 4.77e-04 | 16 | 42 | 2 | GO:0006369 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription termination | 2.18e-03 | 34 | 42 | 2 | GO:0006353 | |
| GeneOntologyCellularComponent | nuclear speck | ACIN1 SRRM1 CACTIN SRSF11 PPIG SREK1 SRSF2 SRSF5 SRSF6 LUC7L3 AKAP17A SRRM2 PNISR RNPS1 CLK2 CDK13 CLK3 SRSF8 RSRC1 CCNL1 SON | 8.85e-25 | 431 | 42 | 21 | GO:0016607 |
| GeneOntologyCellularComponent | nuclear body | ACIN1 SRRM1 CACTIN SRSF11 PPIG SREK1 SRSF2 SRSF5 SRSF6 LUC7L3 AKAP17A SRRM2 PNISR STK35 RNPS1 CLK2 CDK13 CLK3 SRSF8 RSRC1 CCNL1 SON DHX8 | 6.43e-21 | 903 | 42 | 23 | GO:0016604 |
| GeneOntologyCellularComponent | spliceosomal complex | DDX23 SRRM1 LUC7L CACTIN PRPF38B PRPF38A SREK1 SRSF2 LUC7L3 AKAP17A SRRM2 DHX8 | 8.68e-15 | 215 | 42 | 12 | GO:0005681 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DDX23 ACIN1 SNRNP27 SRRM1 LUC7L CACTIN PRPF38B PRPF38A SREK1 SRSF2 LUC7L3 AKAP17A SRRM2 RNPS1 SCAF8 CDK13 CCNL1 DHX8 | 3.78e-11 | 1377 | 42 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | ribonucleoprotein complex | DDX23 SNRNP27 SRRM1 LUC7L CACTIN PRPF38B PRPF38A SREK1 SRSF2 SRSF6 LUC7L3 AKAP17A SRRM2 DHX8 | 4.27e-08 | 1194 | 42 | 14 | GO:1990904 |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 1.44e-06 | 97 | 42 | 5 | GO:0005684 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 1.44e-06 | 97 | 42 | 5 | GO:0071013 | |
| GeneOntologyCellularComponent | ASAP complex | 2.36e-05 | 4 | 42 | 2 | GO:0061574 | |
| GeneOntologyCellularComponent | spliceosomal snRNP complex | 4.09e-05 | 96 | 42 | 4 | GO:0097525 | |
| GeneOntologyCellularComponent | small nuclear ribonucleoprotein complex | 6.25e-05 | 107 | 42 | 4 | GO:0030532 | |
| GeneOntologyCellularComponent | Sm-like protein family complex | 9.45e-05 | 119 | 42 | 4 | GO:0120114 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 1.74e-04 | 54 | 42 | 3 | GO:0071011 | |
| GeneOntologyCellularComponent | U2-type prespliceosome | 5.91e-04 | 18 | 42 | 2 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 5.91e-04 | 18 | 42 | 2 | GO:0071010 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 8.08e-04 | 21 | 42 | 2 | GO:0035145 | |
| GeneOntologyCellularComponent | U2-type catalytic step 2 spliceosome | 1.77e-03 | 31 | 42 | 2 | GO:0071007 | |
| GeneOntologyCellularComponent | U1 snRNP | 2.00e-03 | 33 | 42 | 2 | GO:0005685 | |
| GeneOntologyCellularComponent | nuclear matrix | 2.79e-03 | 140 | 42 | 3 | GO:0016363 | |
| GeneOntologyCellularComponent | U4/U6 x U5 tri-snRNP complex | 4.02e-03 | 47 | 42 | 2 | GO:0046540 | |
| GeneOntologyCellularComponent | spliceosomal tri-snRNP complex | 4.19e-03 | 48 | 42 | 2 | GO:0097526 | |
| GeneOntologyCellularComponent | U2-type precatalytic spliceosome | 4.72e-03 | 51 | 42 | 2 | GO:0071005 | |
| GeneOntologyCellularComponent | nuclear periphery | 4.89e-03 | 171 | 42 | 3 | GO:0034399 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 5.67e-03 | 56 | 42 | 2 | GO:0008023 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 6.69e-03 | 61 | 42 | 2 | GO:0000307 | |
| Domain | - | ACIN1 SRSF11 SREK1 SRSF2 SRSF5 SRSF6 AKAP17A RNPS1 SCAF8 SRSF8 SCAF4 | 1.33e-12 | 244 | 38 | 11 | 3.30.70.330 |
| Domain | Nucleotide-bd_a/b_plait | ACIN1 SRSF11 SREK1 SRSF2 SRSF5 SRSF6 AKAP17A RNPS1 SCAF8 SRSF8 SCAF4 | 2.44e-12 | 258 | 38 | 11 | IPR012677 |
| Domain | RRM | ACIN1 SRSF11 SREK1 SRSF2 SRSF5 SRSF6 RNPS1 SCAF8 SRSF8 SCAF4 | 1.30e-11 | 217 | 38 | 10 | SM00360 |
| Domain | RRM_dom | ACIN1 SRSF11 SREK1 SRSF2 SRSF5 SRSF6 RNPS1 SCAF8 SRSF8 SCAF4 | 2.02e-11 | 227 | 38 | 10 | IPR000504 |
| Domain | RRM | SRSF11 SREK1 SRSF2 SRSF5 SRSF6 AKAP17A RNPS1 SCAF8 SRSF8 SCAF4 | 2.31e-11 | 230 | 38 | 10 | PS50102 |
| Domain | RRM_1 | 2.73e-10 | 208 | 38 | 9 | PF00076 | |
| Domain | PRP38 | 4.03e-06 | 2 | 38 | 2 | IPR005037 | |
| Domain | PRP38 | 4.03e-06 | 2 | 38 | 2 | PF03371 | |
| Domain | DUF1777 | 1.21e-05 | 3 | 38 | 2 | IPR013957 | |
| Domain | LUC7 | 1.21e-05 | 3 | 38 | 2 | PF03194 | |
| Domain | Luc7-rel | 1.21e-05 | 3 | 38 | 2 | IPR004882 | |
| Domain | RNA_pol_II-bd | 8.41e-05 | 7 | 38 | 2 | IPR006903 | |
| Domain | CTD_bind | 8.41e-05 | 7 | 38 | 2 | PF04818 | |
| Domain | RPR | 1.12e-04 | 8 | 38 | 2 | SM00582 | |
| Domain | CID_dom | 1.12e-04 | 8 | 38 | 2 | IPR006569 | |
| Domain | CID | 1.12e-04 | 8 | 38 | 2 | PS51391 | |
| Domain | - | 1.27e-03 | 26 | 38 | 2 | 1.25.40.90 | |
| Domain | ENTH_VHS | 1.58e-03 | 29 | 38 | 2 | IPR008942 | |
| Domain | Ser/Thr_kinase_AS | 5.80e-03 | 357 | 38 | 4 | IPR008271 | |
| Domain | S_TKc | 5.92e-03 | 359 | 38 | 4 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 6.09e-03 | 362 | 38 | 4 | PS00108 | |
| Domain | Protein_kinase_ATP_BS | 7.15e-03 | 379 | 38 | 4 | IPR017441 | |
| Domain | Pkinase | 7.28e-03 | 381 | 38 | 4 | PF00069 | |
| Domain | DEAD/DEAH_box_helicase_dom | 9.67e-03 | 73 | 38 | 2 | IPR011545 | |
| Domain | DEAD | 9.67e-03 | 73 | 38 | 2 | PF00270 | |
| Domain | PROTEIN_KINASE_ATP | 1.37e-02 | 459 | 38 | 4 | PS00107 | |
| Domain | Prot_kinase_dom | 1.70e-02 | 489 | 38 | 4 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.74e-02 | 493 | 38 | 4 | PS50011 | |
| Domain | Helicase_C | 2.00e-02 | 107 | 38 | 2 | PF00271 | |
| Domain | HELICc | 2.00e-02 | 107 | 38 | 2 | SM00490 | |
| Domain | Helicase_C | 2.03e-02 | 108 | 38 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 2.07e-02 | 109 | 38 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.07e-02 | 109 | 38 | 2 | PS51192 | |
| Domain | DEXDc | 2.07e-02 | 109 | 38 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.11e-02 | 110 | 38 | 2 | IPR014001 | |
| Domain | Kinase-like_dom | 2.37e-02 | 542 | 38 | 4 | IPR011009 | |
| Pathway | REACTOME_MRNA_SPLICING | DDX23 ACIN1 SNRNP27 SRRM1 CACTIN SRSF11 PPIG PRPF38A SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 SRSF8 DHX8 | 1.88e-21 | 212 | 32 | 16 | M14033 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | DDX23 ACIN1 SNRNP27 SRRM1 CACTIN SRSF11 PPIG PRPF38A SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 SRSF8 DHX8 | 2.05e-19 | 283 | 32 | 16 | M13087 |
| Pathway | REACTOME_MRNA_SPLICING | DDX23 ACIN1 SNRNP27 SRRM1 CACTIN SRSF11 PRPF38A SRSF2 SRSF5 LUC7L3 SRRM2 RNPS1 DHX8 | 1.87e-16 | 201 | 32 | 13 | MM15411 |
| Pathway | WP_MRNA_PROCESSING | ACIN1 SRRM1 SRSF11 SREK1 SRSF2 RSRC2 SRSF5 SRSF6 SFSWAP AKAP17A RNPS1 SCAF8 CLK2 CLK3 SON DHX8 | 3.48e-16 | 451 | 32 | 16 | MM15946 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | DDX23 ACIN1 SNRNP27 SRRM1 CACTIN SRSF11 PRPF38A SRSF2 SRSF5 LUC7L3 SRRM2 RNPS1 DHX8 | 1.22e-14 | 277 | 32 | 13 | MM15414 |
| Pathway | WP_MRNA_PROCESSING | 1.24e-13 | 126 | 32 | 10 | M39406 | |
| Pathway | KEGG_SPLICEOSOME | DDX23 ACIN1 SNRNP27 PRPF38B PRPF38A SRSF2 SRSF5 SRSF6 SRSF8 DHX8 | 1.34e-13 | 127 | 32 | 10 | M2044 |
| Pathway | REACTOME_METABOLISM_OF_RNA | DDX23 ACIN1 SNRNP27 SRRM1 CACTIN SRSF11 PPIG PRPF38A SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 SRSF8 DHX8 | 5.54e-13 | 724 | 32 | 16 | M16843 |
| Pathway | REACTOME_METABOLISM_OF_RNA | DDX23 ACIN1 SNRNP27 SRRM1 CACTIN SRSF11 PRPF38A SRSF2 SRSF5 LUC7L3 SRRM2 RNPS1 DHX8 | 2.78e-10 | 612 | 32 | 13 | MM15547 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 7.54e-09 | 67 | 32 | 6 | M27694 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.99e-08 | 84 | 32 | 6 | M725 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 2.57e-07 | 62 | 32 | 5 | MM15426 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.33e-06 | 86 | 32 | 5 | MM15413 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 1.94e-04 | 50 | 32 | 3 | M5583 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | DDX23 ACIN1 SNRNP27 SRRM1 RSRP1 LUC7L PPIG PRPF38A SREK1 SRSF2 RSRC2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 CLK2 CDK13 CLK3 SRSF8 RSRC1 SON DHX8 ZRANB2 | 2.80e-30 | 695 | 42 | 24 | 23602568 |
| Pubmed | DDX23 ACIN1 SRRM1 LUC7L SRSF11 PRPF38B PPIG PRPF38A SREK1 SRSF2 RSRC2 SRSF5 SRSF6 SFSWAP LUC7L3 SRRM2 RNPS1 CLK3 SRSF8 RSRC1 SCAF4 SON DHX8 ZRANB2 | 5.18e-30 | 713 | 42 | 24 | 29802200 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DDX23 ACIN1 SRRM1 CACTIN SRSF11 PPIG PRPF38A SREK1 SRSF2 RSRC2 SRSF5 SRSF6 LUC7L3 AKAP17A SRRM2 PNISR RNPS1 CDK13 CLK3 SRSF8 SCAF4 SON DHX8 ZRANB2 | 1.01e-28 | 807 | 42 | 24 | 22681889 |
| Pubmed | DDX23 ACIN1 SNRNP27 SRRM1 LUC7L SRSF11 PRPF38B PPIG PRPF38A SRSF2 RSRC2 SRSF5 SRSF6 SFSWAP LUC7L3 SRRM2 RNPS1 CLK3 SRSF8 RSRC1 SON ZRANB2 | 3.17e-26 | 731 | 42 | 22 | 29298432 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DDX23 ACIN1 SNRNP27 SRRM1 LUC7L SRSF11 PRPF38B PPIG PRPF38A SREK1 SRSF2 RSRC2 SRSF5 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 PNISR CLK3 SCAF4 SON DHX8 ZRANB2 | 1.09e-25 | 1082 | 42 | 24 | 38697112 |
| Pubmed | DDX23 ACIN1 SCAF1 LUC7L PRPF38B PPIG PRPF38A SFSWAP LUC7L3 AKAP17A PNISR CLK2 CLK3 SRSF8 SCAF4 ZRANB2 | 4.70e-24 | 251 | 42 | 16 | 31076518 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DDX23 ACIN1 SNRNP27 SRRM1 SCAF1 LUC7L CACTIN SRSF11 PPIG PRPF38A SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 SRRM2 PNISR RNPS1 CDK13 SRSF8 RSRC1 SCAF4 SON DHX8 | 7.49e-24 | 1294 | 42 | 24 | 30804502 |
| Pubmed | DDX23 SNRNP27 LUC7L SRSF11 PRPF38B PRPF38A SREK1 SRSF2 SRSF5 SRSF6 SFSWAP SRRM3 RNPS1 CLK2 CDK13 CLK3 SRSF8 SRRM4 DHX8 ZRANB2 | 5.87e-23 | 723 | 42 | 20 | 34133714 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ACIN1 SRRM1 SCAF1 CACTIN PRPF38B PPIG PRPF38A SRSF2 SRSF5 SRSF6 SFSWAP SRRM2 PNISR RNPS1 SCAF8 CDK13 SCAF4 CCNL1 SON ZRANB2 | 2.26e-22 | 774 | 42 | 20 | 15302935 |
| Pubmed | DDX23 ACIN1 SNRNP27 SRRM1 SCAF1 LUC7L CACTIN SRSF11 PRPF38B PPIG PRPF38A SRSF2 RSRC2 SRSF5 SFSWAP LUC7L3 AKAP17A RNPS1 CDK13 SRSF8 RSRC1 SCAF4 SON | 9.16e-22 | 1371 | 42 | 23 | 36244648 | |
| Pubmed | SNRNP27 SRRM1 LUC7L PRPF38B SREK1 SRSF2 SFSWAP LUC7L3 AKAP17A RNPS1 CCNL1 SON | 2.72e-21 | 104 | 42 | 12 | 31365120 | |
| Pubmed | DDX23 SNRNP27 SRRM1 SCAF1 LUC7L CACTIN SRSF11 PRPF38B PRPF38A SREK1 SRSF6 SRRM2 PNISR SCAF8 DHX8 | 6.13e-21 | 300 | 42 | 15 | 28561026 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DDX23 ACIN1 SRRM1 SCAF1 LUC7L CACTIN SRSF11 PRPF38B PPIG PRPF38A SREK1 SRSF2 SRSF6 LUC7L3 AKAP17A SRRM2 RNPS1 SCAF8 CLK2 SRSF8 RSRC1 SON | 1.12e-20 | 1318 | 42 | 22 | 30463901 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DDX23 ACIN1 SRRM1 LUC7L CACTIN SRSF11 PRPF38B PPIG SREK1 SRSF2 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 RNPS1 CLK2 CLK3 SON ZRANB2 | 4.54e-18 | 1284 | 42 | 20 | 17353931 |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | SNRNP27 SRRM1 LUC7L SRSF11 PRPF38B PPIG SREK1 SFSWAP LUC7L3 AKAP17A RNPS1 CLK2 CCNL1 | 5.54e-18 | 269 | 42 | 13 | 29511261 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | ACIN1 SRRM1 SCAF1 PPIG PRPF38A SRSF5 SRSF6 SRRM2 RNPS1 CDK13 SON ZRANB2 | 2.04e-16 | 259 | 42 | 12 | 30404004 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | SRRM1 SCAF1 LUC7L SRSF11 PRPF38B PPIG PRPF38A SRSF5 SRSF6 SRRM2 PNISR CDK13 SON | 2.55e-16 | 361 | 42 | 13 | 26167880 |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | ACIN1 SNRNP27 LUC7L PPIG PRPF38A SRSF2 SRSF5 SRSF6 SRRM2 RNPS1 DHX8 | 5.34e-16 | 197 | 42 | 11 | 22365833 |
| Pubmed | ACIN1 SRRM1 LUC7L SRSF11 SREK1 SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 SRRM2 RNPS1 RSRC1 SON DHX8 ZRANB2 | 1.23e-15 | 847 | 42 | 16 | 35850772 | |
| Pubmed | A novel SR-related protein is required for the second step of Pre-mRNA splicing. | 1.96e-15 | 12 | 42 | 6 | 15798186 | |
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 3.64e-15 | 13 | 42 | 6 | 20516191 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | ACIN1 SNRNP27 SCAF1 LUC7L PPIG PRPF38A SRSF2 SRSF5 LUC7L3 RNPS1 SRSF8 SON | 3.74e-15 | 330 | 42 | 12 | 33301849 |
| Pubmed | ACIN1 SRRM1 SRSF11 SREK1 SRSF2 SRSF5 SRSF6 AKAP17A RNPS1 SCAF8 SCAF4 SON | 6.80e-15 | 347 | 42 | 12 | 16033648 | |
| Pubmed | SCAF1 PRPF38B PRPF38A SREK1 SRSF2 RSRC2 SFSWAP AKAP17A PNISR SCAF8 CDK13 CLK3 RSRC1 SCAF4 CCNL1 SON DHX8 ZRANB2 | 3.08e-14 | 1497 | 42 | 18 | 31527615 | |
| Pubmed | LUC7L SRSF11 PRPF38B PRPF38A SREK1 SRSF6 LUC7L3 SRRM2 SRSF8 RSRC1 | 5.32e-14 | 206 | 42 | 10 | 34185411 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX23 ACIN1 SRRM1 LUC7L SRSF11 SREK1 SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 SCAF8 DHX8 | 1.16e-13 | 582 | 42 | 13 | 20467437 |
| Pubmed | 4.50e-13 | 255 | 42 | 10 | 15324660 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 4.73e-13 | 169 | 42 | 9 | 23084401 | |
| Pubmed | DDX23 ACIN1 SRRM1 LUC7L SRSF11 PPIG SREK1 SRSF6 LUC7L3 SRRM2 RNPS1 CDK13 ZRANB2 | 5.15e-13 | 655 | 42 | 13 | 35819319 | |
| Pubmed | 1.20e-12 | 115 | 42 | 8 | 17332742 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX23 ACIN1 SRRM1 SCAF1 LUC7L SRSF11 SRSF2 SRSF6 LUC7L3 SRRM2 RNPS1 SCAF4 SON DHX8 | 8.27e-12 | 1024 | 42 | 14 | 24711643 |
| Pubmed | ACIN1 SRRM1 LUC7L PPIG PPP2R5B PRPF38A RSRC2 SRSF5 SRSF6 SRRM2 RNPS1 | 1.15e-11 | 491 | 42 | 11 | 36273042 | |
| Pubmed | DDX23 ACIN1 SRRM1 CACTIN SRSF11 SRRM2 PNISR CDK13 SCAF4 SON ZRANB2 | 1.58e-11 | 506 | 42 | 11 | 30890647 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 2.44e-11 | 96 | 42 | 7 | 25948554 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | ACIN1 SRRM1 RSRP1 SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 SRRM2 PNISR RNPS1 CLK3 SCAF4 | 3.68e-11 | 922 | 42 | 13 | 27609421 |
| Pubmed | 6.02e-11 | 109 | 42 | 7 | 12226669 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | SRRM1 SRSF11 SRSF2 RSRC2 LUC7L3 AKAP17A SRRM2 CDK13 SRRM4 RLIM | 6.18e-11 | 420 | 42 | 10 | 28065597 |
| Pubmed | 6.33e-11 | 188 | 42 | 8 | 29721183 | ||
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 7.41e-11 | 57 | 42 | 6 | 14559993 | |
| Pubmed | 2.30e-10 | 9 | 42 | 4 | 19857271 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ACIN1 SRRM1 LUC7L PPIG SRSF2 SRSF5 SRRM2 RNPS1 CDK13 RSRC1 ZRANB2 | 2.88e-10 | 665 | 42 | 11 | 30457570 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | SRRM1 LUC7L CACTIN SRSF11 SREK1 SRSF2 SRSF6 LUC7L3 CDK13 CLK3 SON | 3.53e-10 | 678 | 42 | 11 | 30209976 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 4.18e-10 | 361 | 42 | 9 | 30344098 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DDX23 SRRM1 LUC7L SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 SCAF8 CDK13 RSRC1 SON DHX8 ZRANB2 | 5.80e-10 | 1415 | 42 | 14 | 28515276 |
| Pubmed | 6.02e-10 | 11 | 42 | 4 | 9472028 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.03e-09 | 163 | 42 | 7 | 22113938 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DDX23 ACIN1 SCAF1 SRSF11 SREK1 SRSF2 SRSF6 SFSWAP LUC7L3 SRRM2 SON ZRANB2 | 1.32e-09 | 989 | 42 | 12 | 36424410 |
| Pubmed | ACIN1 SRRM1 LUC7L SRSF11 PRPF38B PPIG SRSF2 RSRC2 SRSF5 SRSF6 SRRM2 RNPS1 DHX8 | 1.47e-09 | 1247 | 42 | 13 | 27684187 | |
| Pubmed | CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | 1.61e-09 | 94 | 42 | 6 | 37468549 | |
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 28589370 | ||
| Pubmed | 1.64e-09 | 3 | 42 | 3 | 28062851 | ||
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 3.53e-09 | 107 | 42 | 6 | 20508642 | |
| Pubmed | DDX23 ACIN1 SRRM1 SRSF11 PPIG PRPF38A SRSF5 SRSF6 SRRM2 RNPS1 | 4.82e-09 | 660 | 42 | 10 | 32780723 | |
| Pubmed | 5.17e-09 | 114 | 42 | 6 | 31553912 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | DDX23 SRRM1 LUC7L SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 CDK13 SCAF4 | 5.56e-09 | 670 | 42 | 10 | 22990118 |
| Pubmed | 6.54e-09 | 4 | 42 | 3 | 10908574 | ||
| Pubmed | 8.02e-09 | 57 | 42 | 5 | 21555454 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.02e-08 | 714 | 42 | 10 | 28302793 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DDX23 SRRM1 LUC7L CACTIN LUC7L3 AKAP17A SRRM2 CDK13 CLK3 SON DHX8 | 1.16e-08 | 949 | 42 | 11 | 36574265 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ACIN1 SRRM1 SRSF11 SREK1 SRSF2 SRSF6 SFSWAP LUC7L3 SRRM2 SCAF4 SON | 1.23e-08 | 954 | 42 | 11 | 36373674 |
| Pubmed | 1.46e-08 | 239 | 42 | 7 | 26641092 | ||
| Pubmed | Identification and characterization of a novel serine-arginine-rich splicing regulatory protein. | 1.63e-08 | 5 | 42 | 3 | 10757789 | |
| Pubmed | 2.35e-08 | 399 | 42 | 8 | 35987950 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 3.14e-08 | 154 | 42 | 6 | 16055720 | |
| Pubmed | SR proteins: a conserved family of pre-mRNA splicing factors. | 3.27e-08 | 6 | 42 | 3 | 1577277 | |
| Pubmed | Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. | 3.27e-08 | 6 | 42 | 3 | 17361132 | |
| Pubmed | 3.27e-08 | 6 | 42 | 3 | 9531537 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 3.68e-08 | 605 | 42 | 9 | 28977666 | |
| Pubmed | 4.51e-08 | 80 | 42 | 5 | 11991638 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 7.94e-08 | 180 | 42 | 6 | 30110629 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.07e-07 | 486 | 42 | 8 | 30940648 | |
| Pubmed | 1.53e-07 | 102 | 42 | 5 | 14759258 | ||
| Pubmed | Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. | 1.95e-07 | 10 | 42 | 3 | 10983978 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.29e-07 | 358 | 42 | 7 | 32460013 | |
| Pubmed | Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. | 2.68e-07 | 11 | 42 | 3 | 14729963 | |
| Pubmed | 4.88e-07 | 245 | 42 | 6 | 21182205 | ||
| Pubmed | 5.06e-07 | 403 | 42 | 7 | 35253629 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 5.14e-07 | 130 | 42 | 5 | 35545047 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.68e-07 | 410 | 42 | 7 | 26949251 | |
| Pubmed | SRRM1 SCAF1 CACTIN SREK1 RSRC2 SFSWAP AKAP17A SRRM2 RNPS1 SON | 6.43e-07 | 1116 | 42 | 10 | 31753913 | |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 6.67e-07 | 137 | 42 | 5 | 37039823 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACIN1 SCAF1 SREK1 SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 DHX8 ZRANB2 | 6.97e-07 | 1425 | 42 | 11 | 30948266 |
| Pubmed | 7.23e-07 | 425 | 42 | 7 | 24999758 | ||
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 8.53e-07 | 60 | 42 | 4 | 29055695 | |
| Pubmed | 9.95e-07 | 653 | 42 | 8 | 22586326 | ||
| Pubmed | 1.18e-06 | 65 | 42 | 4 | 22379092 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 33095160 | ||
| Pubmed | Clk2 and B56β mediate insulin-regulated assembly of the PP2A phosphatase holoenzyme complex on Akt. | 1.42e-06 | 2 | 42 | 2 | 21329884 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 29512856 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 10668804 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 31104839 | ||
| Pubmed | Cellular differentiation state modulates the mRNA export activity of SR proteins. | 1.42e-06 | 2 | 42 | 2 | 28592444 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 33050987 | ||
| Pubmed | SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA. | 1.42e-06 | 2 | 42 | 2 | 20427542 | |
| Pubmed | Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication. | 1.42e-06 | 2 | 42 | 2 | 25889056 | |
| Pubmed | SON controls cell-cycle progression by coordinated regulation of RNA splicing. | 1.42e-06 | 2 | 42 | 2 | 21504830 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 34312180 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 9637771 | ||
| Pubmed | 1.57e-06 | 19 | 42 | 3 | 25263594 | ||
| Pubmed | Splicing factor TRA2B is required for neural progenitor survival. | 1.57e-06 | 19 | 42 | 3 | 23818142 | |
| Interaction | SRPK2 interactions | DDX23 ACIN1 SNRNP27 SRRM1 SCAF1 RSRP1 LUC7L CACTIN SRSF11 PRPF38B PPIG PRPF38A SREK1 SRSF2 RSRC2 SRSF5 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 PNISR RNPS1 CLK2 CDK13 CLK3 SRSF8 RSRC1 SCAF4 SON DHX8 ZRANB2 | 2.32e-38 | 717 | 42 | 32 | int:SRPK2 |
| Interaction | RNPS1 interactions | DDX23 ACIN1 SRRM1 LUC7L CACTIN SRSF11 PPIG PRPF38A SREK1 SRSF2 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 PNISR RNPS1 CLK2 CLK3 SRRM4 SCAF4 CCNL1 SON DHX8 | 7.82e-30 | 425 | 42 | 24 | int:RNPS1 |
| Interaction | SRSF4 interactions | DDX23 ACIN1 SRRM1 SCAF1 SRSF11 PPIG PRPF38A SREK1 SRSF2 SRSF5 SRSF6 AKAP17A SRRM2 RNPS1 CLK2 CDK13 CLK3 SRSF8 SRRM4 SON DHX8 | 8.54e-28 | 300 | 42 | 21 | int:SRSF4 |
| Interaction | SRSF11 interactions | DDX23 ACIN1 SRRM1 LUC7L SRSF11 PRPF38B PPIG SREK1 SRSF2 SRSF6 SRRM2 PNISR RNPS1 CLK2 CLK3 SRRM4 SON DHX8 ZRANB2 | 1.77e-27 | 203 | 42 | 19 | int:SRSF11 |
| Interaction | JMJD6 interactions | SCAF1 LUC7L CACTIN SRSF11 PRPF38B PPIG PRPF38A SREK1 RSRC2 SFSWAP LUC7L3 AKAP17A SCAF8 CLK3 RSRC1 SCAF4 CCNL1 SON DHX8 | 2.15e-27 | 205 | 42 | 19 | int:JMJD6 |
| Interaction | SNRNP70 interactions | DDX23 ACIN1 SRRM1 SCAF1 LUC7L CACTIN SRSF11 PRPF38B PPIG PRPF38A SREK1 SRSF2 RSRC2 SRSF5 SRSF6 SFSWAP LUC7L3 SRRM2 RNPS1 CLK2 CLK3 SRSF8 SRRM4 RSRC1 SCAF4 SON DHX8 ZRANB2 | 3.63e-27 | 984 | 42 | 28 | int:SNRNP70 |
| Interaction | SRSF6 interactions | DDX23 ACIN1 SRRM1 SCAF1 LUC7L CACTIN SRSF11 PRPF38B PPIG PRPF38A SREK1 SRSF2 SRSF5 SRSF6 AKAP17A SRRM2 RNPS1 CLK2 CDK13 CLK3 SRSF8 SON DHX8 | 2.39e-26 | 503 | 42 | 23 | int:SRSF6 |
| Interaction | SRPK1 interactions | DDX23 ACIN1 SRRM1 RSRP1 LUC7L SRSF11 PPIG PRPF38A SREK1 SRSF2 RSRC2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 CLK3 SRSF8 RSRC1 SON DHX8 ZRANB2 | 3.50e-25 | 477 | 42 | 22 | int:SRPK1 |
| Interaction | SRSF7 interactions | DDX23 ACIN1 SRRM1 SCAF1 LUC7L SRSF11 PPIG PRPF38A SREK1 SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 CLK2 CLK3 SRSF8 SON DHX8 ZRANB2 | 1.40e-24 | 425 | 42 | 21 | int:SRSF7 |
| Interaction | ZC3H18 interactions | DDX23 ACIN1 SNRNP27 SRRM1 LUC7L SRSF11 PRPF38B PPIG PRPF38A SRSF2 RSRC2 SRSF5 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 RNPS1 CLK2 CLK3 SRSF8 RSRC1 SON DHX8 ZRANB2 | 8.36e-24 | 877 | 42 | 25 | int:ZC3H18 |
| Interaction | DHX8 interactions | DDX23 SRRM1 SCAF1 CACTIN SRSF11 PRPF38A RSRC2 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 PNISR RNPS1 CDK13 SON DHX8 ZRANB2 | 1.21e-22 | 292 | 42 | 18 | int:DHX8 |
| Interaction | LUC7L interactions | ACIN1 SRRM1 LUC7L SRSF11 PRPF38B PPIG SRSF6 LUC7L3 SRRM2 RNPS1 CLK2 CLK3 SRSF8 SRRM4 RSRC1 SCAF4 ZRANB2 | 2.48e-22 | 242 | 42 | 17 | int:LUC7L |
| Interaction | SRPK3 interactions | ACIN1 SRRM1 LUC7L CACTIN SRSF11 PRPF38A SREK1 SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 CLK2 CDK13 SCAF4 SON | 2.76e-22 | 190 | 42 | 16 | int:SRPK3 |
| Interaction | CLK2 interactions | ACIN1 SNRNP27 SRRM1 RSRP1 LUC7L CACTIN SRSF11 PRPF38A SRSF6 LUC7L3 SRRM2 RNPS1 CLK2 CLK3 SRSF8 SON | 4.22e-22 | 195 | 42 | 16 | int:CLK2 |
| Interaction | DDX23 interactions | DDX23 ACIN1 SRRM1 SCAF1 CACTIN SRSF11 PPIG SREK1 RSRC2 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 PNISR RNPS1 CDK13 RSRC1 DHX8 ZRANB2 | 7.39e-22 | 480 | 42 | 20 | int:DDX23 |
| Interaction | PNN interactions | DDX23 ACIN1 SRRM1 SCAF1 LUC7L SRSF11 PPIG SREK1 SRSF6 SFSWAP AKAP17A SRRM2 PNISR RNPS1 CLK2 CLK3 DHX8 | 1.12e-20 | 302 | 42 | 17 | int:PNN |
| Interaction | SAP18 interactions | DDX23 ACIN1 SRRM1 SCAF1 SRSF11 PRPF38B PPIG SREK1 SRSF5 SRSF6 SRRM2 RNPS1 CLK2 CLK3 SRSF8 SON DHX8 | 1.33e-20 | 305 | 42 | 17 | int:SAP18 |
| Interaction | MECP2 interactions | DDX23 ACIN1 SNRNP27 SRRM1 LUC7L SRSF11 PRPF38B PPIG PRPF38A SREK1 SRSF2 RSRC2 SRSF5 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 PNISR CLK3 SRSF8 SCAF4 SON DHX8 ZRANB2 | 9.61e-20 | 1287 | 42 | 25 | int:MECP2 |
| Interaction | NKAPD1 interactions | DDX23 ACIN1 SRRM1 SCAF1 CACTIN PPIG PRPF38A SRRM2 RNPS1 CLK2 CLK3 SRSF8 CCNL1 DHX8 | 1.06e-19 | 161 | 42 | 14 | int:NKAPD1 |
| Interaction | CLK1 interactions | DDX23 SRRM1 SRSF11 PPIG PRPF38A SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 CLK2 CLK3 SRSF8 SRRM4 | 1.63e-19 | 219 | 42 | 15 | int:CLK1 |
| Interaction | SRSF1 interactions | SRRM1 SCAF1 LUC7L SRSF11 PPIG SREK1 SRSF2 SRSF5 SRSF6 LUC7L3 AKAP17A SRRM2 RNPS1 CLK2 CDK13 CLK3 RSRC1 SON DHX8 | 6.89e-19 | 570 | 42 | 19 | int:SRSF1 |
| Interaction | SNIP1 interactions | ACIN1 SRRM1 SCAF1 PPIG PRPF38A SRSF5 SRSF6 SRRM2 RNPS1 CLK2 CDK13 CLK3 SRSF8 SRRM4 SON DHX8 ZRANB2 | 2.68e-18 | 417 | 42 | 17 | int:SNIP1 |
| Interaction | LUC7L2 interactions | ACIN1 SNRNP27 LUC7L SRSF11 PRPF38A SREK1 SRSF6 LUC7L3 SRRM2 RNPS1 CLK2 CLK3 SRSF8 SRRM4 DHX8 ZRANB2 | 6.16e-18 | 353 | 42 | 16 | int:LUC7L2 |
| Interaction | CLK3 interactions | ACIN1 SRRM1 RSRP1 LUC7L SRSF11 PRPF38B PPIG SRSF5 SRSF6 SRRM2 RNPS1 CLK2 CLK3 SRSF8 | 9.08e-18 | 220 | 42 | 14 | int:CLK3 |
| Interaction | RAD18 interactions | DDX23 ACIN1 SCAF1 LUC7L PRPF38B PPIG PRPF38A SFSWAP LUC7L3 AKAP17A SRRM2 PNISR CLK2 CLK3 SRSF8 SCAF4 ZRANB2 | 1.25e-17 | 457 | 42 | 17 | int:RAD18 |
| Interaction | SRRM4 interactions | 3.53e-17 | 37 | 42 | 9 | int:SRRM4 | |
| Interaction | SNRNP40 interactions | DDX23 ACIN1 SNRNP27 SRRM1 SCAF1 CACTIN SREK1 SRSF6 SFSWAP LUC7L3 AKAP17A SRRM2 PNISR SCAF8 RSRC1 SCAF4 SON DHX8 | 1.36e-16 | 637 | 42 | 18 | int:SNRNP40 |
| Interaction | PRPF40A interactions | DDX23 ACIN1 SNRNP27 SRRM1 LUC7L SRSF11 PPIG PRPF38A SREK1 SRRM2 RNPS1 CDK13 SCAF4 CCNL1 SON DHX8 | 2.49e-16 | 446 | 42 | 16 | int:PRPF40A |
| Interaction | SRRM2 interactions | DDX23 ACIN1 SRRM1 LUC7L SRSF11 SRSF5 SRSF6 AKAP17A SRRM2 SRRM3 RNPS1 CLK2 CLK3 SON DHX8 ZRANB2 | 4.34e-16 | 462 | 42 | 16 | int:SRRM2 |
| Interaction | SNRPA interactions | DDX23 ACIN1 SRRM1 LUC7L SRSF11 PPIG SRSF2 LUC7L3 SRRM2 RNPS1 CLK2 SRSF8 RSRC1 SCAF4 SON DHX8 | 8.42e-16 | 482 | 42 | 16 | int:SNRPA |
| Interaction | IFI6 interactions | SNRNP27 CACTIN PRPF38B PPIG PRPF38A SREK1 RSRC2 SFSWAP RSRC1 | 1.47e-15 | 54 | 42 | 9 | int:IFI6 |
| Interaction | PRP4K interactions | DDX23 ACIN1 LUC7L CACTIN SRSF11 PRPF38A SRSF5 SRSF6 SRRM2 RNPS1 CLK2 CLK3 DHX8 ZRANB2 | 2.54e-15 | 329 | 42 | 14 | int:PRP4K |
| Interaction | SRSF3 interactions | SRRM1 SCAF1 CACTIN SRSF11 PPIG PRPF38A SREK1 SRSF2 SRSF5 SRSF6 SRRM2 RNPS1 CLK2 CDK13 CLK3 SRSF8 | 2.93e-15 | 522 | 42 | 16 | int:SRSF3 |
| Interaction | NR2C2 interactions | DDX23 ACIN1 SRRM1 SCAF1 LUC7L CACTIN SRSF11 PRPF38B PPIG PRPF38A SREK1 SRSF2 SRSF6 LUC7L3 AKAP17A SRRM2 RNPS1 SCAF8 CLK2 SRSF8 RSRC1 SON | 3.93e-15 | 1403 | 42 | 22 | int:NR2C2 |
| Interaction | ZRANB2 interactions | DDX23 ACIN1 LUC7L SRSF11 SREK1 SRSF2 LUC7L3 AKAP17A SRRM2 SRRM3 DHX8 ZRANB2 | 5.25e-15 | 199 | 42 | 12 | int:ZRANB2 |
| Interaction | SRRM1 interactions | DDX23 ACIN1 SRRM1 LUC7L SRSF11 SRSF2 SRSF5 SRSF6 SRRM2 RNPS1 CLK2 CLK3 SRRM4 DHX8 | 5.52e-15 | 348 | 42 | 14 | int:SRRM1 |
| Interaction | SNRPC interactions | DDX23 ACIN1 SRRM1 LUC7L CACTIN PRPF38A SREK1 LUC7L3 SRRM2 RNPS1 CLK3 SRSF8 SCAF4 SON DHX8 | 5.55e-15 | 440 | 42 | 15 | int:SNRPC |
| Interaction | ACIN1 interactions | DDX23 ACIN1 SRRM1 LUC7L SRSF11 SRSF6 SRRM2 RNPS1 CLK2 CLK3 SCAF4 SON ZRANB2 | 2.46e-14 | 301 | 42 | 13 | int:ACIN1 |
| Interaction | ZCCHC10 interactions | SRRM1 CACTIN SRSF11 PPIG PRPF38A SREK1 SFSWAP AKAP17A SRRM2 CLK2 SON DHX8 | 4.07e-14 | 236 | 42 | 12 | int:ZCCHC10 |
| Interaction | U2AF2 interactions | DDX23 ACIN1 SRRM1 SCAF1 LUC7L SRSF11 SRSF2 SRSF5 SRSF6 SRRM2 RNPS1 CLK2 CLK3 SRSF8 SON ZRANB2 | 8.94e-14 | 651 | 42 | 16 | int:U2AF2 |
| Interaction | UBR5 interactions | DDX23 ACIN1 SNRNP27 SRRM1 LUC7L PRPF38B SREK1 SRSF2 SFSWAP LUC7L3 AKAP17A RNPS1 CLK3 CCNL1 SON | 9.12e-14 | 533 | 42 | 15 | int:UBR5 |
| Interaction | LINC02910 interactions | SNRNP27 CACTIN PRPF38B PPIG PRPF38A SREK1 RSRC2 SFSWAP RSRC1 | 3.06e-13 | 95 | 42 | 9 | int:LINC02910 |
| Interaction | SRSF5 interactions | SRRM1 SCAF1 PPIG PRPF38A SREK1 SRSF2 SRSF5 SRSF6 AKAP17A SRRM2 CDK13 CLK3 SRSF8 SON | 3.79e-13 | 474 | 42 | 14 | int:SRSF5 |
| Interaction | SRSF8 interactions | 4.08e-13 | 98 | 42 | 9 | int:SRSF8 | |
| Interaction | AKAP17A interactions | 4.48e-13 | 99 | 42 | 9 | int:AKAP17A | |
| Interaction | RBBP6 interactions | 5.31e-13 | 216 | 42 | 11 | int:RBBP6 | |
| Interaction | RBM39 interactions | DDX23 ACIN1 SRRM1 SRSF11 PPIG PRPF38A SREK1 SRSF2 SRSF6 SRRM2 PNISR RNPS1 CLK2 CLK3 SRRM4 RSRC1 SON DHX8 | 6.56e-13 | 1042 | 42 | 18 | int:RBM39 |
| Interaction | IFI27L1 interactions | 8.11e-13 | 65 | 42 | 8 | int:IFI27L1 | |
| Interaction | PRPF38A interactions | 9.43e-13 | 161 | 42 | 10 | int:PRPF38A | |
| Interaction | U2AF1 interactions | DDX23 ACIN1 PRPF38A SRSF2 SRSF5 SRRM2 RNPS1 CLK2 SRRM4 SON ZRANB2 | 1.61e-12 | 239 | 42 | 11 | int:U2AF1 |
| Interaction | SREK1 interactions | DDX23 SRSF11 SREK1 SRSF2 SRSF5 SRSF6 RNPS1 SRSF8 SRRM4 ZRANB2 | 3.41e-12 | 183 | 42 | 10 | int:SREK1 |
| Interaction | PPIG interactions | 4.40e-12 | 127 | 42 | 9 | int:PPIG | |
| Interaction | MYCN interactions | DDX23 ACIN1 SNRNP27 SRRM1 SCAF1 LUC7L SRSF11 PRPF38B PPIG SRSF2 SRSF5 SRSF6 SFSWAP SRRM2 RNPS1 CDK13 RSRC1 SON ZRANB2 | 5.95e-12 | 1373 | 42 | 19 | int:MYCN |
| Interaction | ECT2 interactions | DDX23 ACIN1 SRRM1 CACTIN PRPF38B PRPF38A SREK1 SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 SRSF8 SON DHX8 | 9.85e-12 | 887 | 42 | 16 | int:ECT2 |
| Interaction | CFAP20 interactions | 1.31e-11 | 91 | 42 | 8 | int:CFAP20 | |
| Interaction | TRA2B interactions | SRRM1 SRSF11 SREK1 SRSF2 SRSF5 SRSF6 SRRM2 RNPS1 CLK2 CLK3 SRSF8 ZRANB2 | 1.31e-11 | 385 | 42 | 12 | int:TRA2B |
| Interaction | PRPF3 interactions | DDX23 SNRNP27 SRRM1 CACTIN SRSF2 SRSF5 SRRM2 RNPS1 CDK13 SON DHX8 | 1.36e-11 | 291 | 42 | 11 | int:PRPF3 |
| Interaction | UQCR11 interactions | 1.45e-11 | 53 | 42 | 7 | int:UQCR11 | |
| Interaction | CIT interactions | DDX23 ACIN1 SNRNP27 SRRM1 SCAF1 LUC7L CACTIN PRPF38B PRPF38A SREK1 SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 SRSF8 SON DHX8 | 1.54e-11 | 1450 | 42 | 19 | int:CIT |
| Interaction | HERC2 interactions | SNRNP27 SRRM1 LUC7L SRSF11 PRPF38B PPIG SREK1 SFSWAP LUC7L3 AKAP17A RNPS1 CLK2 CCNL1 | 1.65e-11 | 503 | 42 | 13 | int:HERC2 |
| Interaction | ZC3H11A interactions | 1.69e-11 | 215 | 42 | 10 | int:ZC3H11A | |
| Interaction | PIP4K2A interactions | DDX23 ACIN1 PRPF38B PPIG PRPF38A SRRM2 PNISR RNPS1 SRSF8 ZRANB2 | 1.77e-11 | 216 | 42 | 10 | int:PIP4K2A |
| Interaction | UBE2O interactions | ACIN1 SRRM1 LUC7L PPIG PPP2R5B PRPF38A RSRC2 SRSF5 SRSF6 AKAP17A SRRM2 RNPS1 CDK13 CLK3 CCNL1 | 2.56e-11 | 790 | 42 | 15 | int:UBE2O |
| Interaction | CPSF6 interactions | DDX23 ACIN1 SRRM1 RSRP1 PPIG SRSF6 AKAP17A SRRM2 RNPS1 CLK2 SCAF4 SON DHX8 | 2.88e-11 | 526 | 42 | 13 | int:CPSF6 |
| Interaction | FOLR1 interactions | LUC7L SRSF11 PRPF38B PRPF38A SREK1 SRSF6 LUC7L3 SRRM2 SRSF8 RSRC1 | 2.89e-11 | 227 | 42 | 10 | int:FOLR1 |
| Interaction | CDK12 interactions | 3.02e-11 | 228 | 42 | 10 | int:CDK12 | |
| Interaction | DOT1L interactions | ACIN1 SRRM1 LUC7L SRSF11 SRSF2 SRSF5 SRSF6 SFSWAP LUC7L3 SRRM2 RNPS1 RSRC1 SON DHX8 ZRANB2 | 3.45e-11 | 807 | 42 | 15 | int:DOT1L |
| Interaction | CD2BP2 interactions | DDX23 SNRNP27 SRRM1 SRSF11 PRPF38B SRSF6 SRRM2 PNISR RSRC1 DHX8 | 3.59e-11 | 232 | 42 | 10 | int:CD2BP2 |
| Interaction | TRA2A interactions | SRRM1 LUC7L SRSF11 PPIG SRSF5 SRSF6 SRRM2 RNPS1 CLK2 CLK3 SRSF8 | 5.23e-11 | 330 | 42 | 11 | int:TRA2A |
| Interaction | THRAP3 interactions | DDX23 ACIN1 LUC7L SRSF11 PPIG SREK1 SRSF6 RNPS1 CLK2 CLK3 SRSF8 DHX8 | 6.68e-11 | 443 | 42 | 12 | int:THRAP3 |
| Interaction | ZBTB2 interactions | ACIN1 SNRNP27 SCAF1 LUC7L PPIG PRPF38A SRSF2 SRSF5 LUC7L3 RNPS1 SRSF8 SON | 8.01e-11 | 450 | 42 | 12 | int:ZBTB2 |
| Interaction | RSBN1L interactions | 8.22e-11 | 114 | 42 | 8 | int:RSBN1L | |
| Interaction | GPATCH8 interactions | 8.82e-11 | 115 | 42 | 8 | int:GPATCH8 | |
| Interaction | KIF23 interactions | DDX23 ACIN1 SRRM1 PRPF38B PPIG PRPF38A SRSF2 SRSF5 SRSF6 LUC7L3 AKAP17A SRRM2 RNPS1 SRSF8 SON ZRANB2 | 9.29e-11 | 1031 | 42 | 16 | int:KIF23 |
| Interaction | CHERP interactions | DDX23 SNRNP27 LUC7L PRPF38A SRSF5 SRSF6 SFSWAP RNPS1 CLK3 DHX8 | 1.19e-10 | 262 | 42 | 10 | int:CHERP |
| Interaction | OBSL1 interactions | DDX23 ACIN1 SRRM1 SCAF1 SRSF11 PRPF38B SRSF2 SRSF6 LUC7L3 SRRM2 RNPS1 SCAF4 SON DHX8 ZRANB2 | 1.64e-10 | 902 | 42 | 15 | int:OBSL1 |
| Interaction | PPIE interactions | 2.43e-10 | 282 | 42 | 10 | int:PPIE | |
| Interaction | EIF4A3 interactions | ACIN1 SRRM1 CACTIN PRPF38A SRSF2 SRSF5 SRSF6 AKAP17A SRRM2 RNPS1 SON RLIM | 2.62e-10 | 499 | 42 | 12 | int:EIF4A3 |
| Interaction | NKAP interactions | 2.68e-10 | 132 | 42 | 8 | int:NKAP | |
| Interaction | SRSF2 interactions | SRRM1 SRSF11 SREK1 SRSF2 SRSF5 SRSF6 RNPS1 SRSF8 CCNL1 ZRANB2 | 3.20e-10 | 290 | 42 | 10 | int:SRSF2 |
| Interaction | CSNK2A1 interactions | ACIN1 SRRM1 LUC7L CACTIN SRSF11 PRPF38A SREK1 SRSF2 AKAP17A SRRM2 RNPS1 CLK2 RSRC1 CCNL1 ZRANB2 | 3.68e-10 | 956 | 42 | 15 | int:CSNK2A1 |
| Interaction | SON interactions | 3.71e-10 | 208 | 42 | 9 | int:SON | |
| Interaction | SNRPB interactions | DDX23 ACIN1 SRRM1 PPIG LUC7L3 SRRM2 RNPS1 RSRC1 SCAF4 SON DHX8 RLIM | 3.93e-10 | 517 | 42 | 12 | int:SNRPB |
| Interaction | NKTR interactions | 6.64e-10 | 90 | 42 | 7 | int:NKTR | |
| Interaction | NFKBIL1 interactions | 8.38e-10 | 93 | 42 | 7 | int:NFKBIL1 | |
| Interaction | RNF113A interactions | DDX23 ACIN1 SRRM1 LUC7L SRSF11 PPIG SREK1 SRSF6 LUC7L3 SRRM2 RNPS1 CDK13 ZRANB2 | 8.40e-10 | 692 | 42 | 13 | int:RNF113A |
| Interaction | RBM25 interactions | DDX23 SRRM1 LUC7L SRSF11 PRPF38A SREK1 SRRM2 RNPS1 SRRM4 DHX8 | 9.09e-10 | 323 | 42 | 10 | int:RBM25 |
| Interaction | HDLBP interactions | DDX23 SNRNP27 SRRM1 LUC7L SRSF11 PRPF38B SRSF2 SRSF5 SFSWAP LUC7L3 AKAP17A RNPS1 SRSF8 SCAF4 | 9.61e-10 | 855 | 42 | 14 | int:HDLBP |
| Interaction | CDC5L interactions | DDX23 SNRNP27 SRRM1 LUC7L CACTIN SREK1 SRSF2 SRSF5 SRSF6 SRRM2 PNISR SCAF8 SON DHX8 | 9.61e-10 | 855 | 42 | 14 | int:CDC5L |
| Interaction | PRPF6 interactions | 1.33e-09 | 336 | 42 | 10 | int:PRPF6 | |
| Interaction | ZC3H14 interactions | 1.92e-09 | 169 | 42 | 8 | int:ZC3H14 | |
| Interaction | MAGEB2 interactions | 1.92e-09 | 349 | 42 | 10 | int:MAGEB2 | |
| Interaction | MAGOH interactions | 3.03e-09 | 264 | 42 | 9 | int:MAGOH | |
| Interaction | SRSF10 interactions | 3.81e-09 | 271 | 42 | 9 | int:SRSF10 | |
| Interaction | SNRPF interactions | 4.92e-09 | 385 | 42 | 10 | int:SNRPF | |
| Interaction | PRC1 interactions | DDX23 ACIN1 SRRM1 PRPF38B PRPF38A SRSF2 SRSF5 SRSF6 LUC7L3 SRRM2 RNPS1 SRSF8 SON DHX8 | 5.08e-09 | 973 | 42 | 14 | int:PRC1 |
| Interaction | RNF151 interactions | 6.00e-09 | 123 | 42 | 7 | int:RNF151 | |
| Interaction | C1orf35 interactions | 1.04e-08 | 304 | 42 | 9 | int:C1orf35 | |
| Interaction | ACTC1 interactions | DDX23 ACIN1 SRRM1 CACTIN SRSF11 SRRM2 PNISR CDK13 SCAF4 SON RLIM ZRANB2 | 1.08e-08 | 694 | 42 | 12 | int:ACTC1 |
| Interaction | YWHAG interactions | ACIN1 SRRM1 LUC7L SRSF11 PRPF38B PPIG LUC7L3 AKAP17A SRRM2 RNPS1 CLK2 CLK3 SRSF8 RSRC1 SON | 1.40e-08 | 1248 | 42 | 15 | int:YWHAG |
| Cytoband | 1p31 | 1.70e-04 | 21 | 42 | 2 | 1p31 | |
| Cytoband | 16p13.3 | 1.46e-03 | 244 | 42 | 3 | 16p13.3 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 2.60e-12 | 12 | 25 | 5 | 737 | |
| GeneFamily | RNA binding motif containing | 2.96e-10 | 213 | 25 | 8 | 725 | |
| GeneFamily | ASAP complex|SIN3 histone deacetylase complex | 5.50e-06 | 3 | 25 | 2 | 1236 | |
| GeneFamily | CDC like kinases | 1.10e-05 | 4 | 25 | 2 | 480 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | ACIN1 SNRNP27 SRRM1 RSRP1 SRSF11 PRPF38B PPIG SRSF2 RSRC2 SRSF6 LUC7L3 SRRM2 CCNL1 SON ZRANB2 | 1.18e-10 | 1144 | 42 | 15 | MM3843 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | PRICKLE2 ACIN1 LUC7L SRSF11 PRPF38B SREK1 LUC7L3 SRRM2 PNISR SCAF8 | 8.72e-10 | 417 | 42 | 10 | M39224 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | DDX23 SRRM1 SCAF1 CACTIN SRSF11 PRPF38A SRSF2 RSRC2 SRSF6 LUC7L3 RNPS1 SON ZRANB2 | 1.31e-08 | 1129 | 42 | 13 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | DDX23 SRRM1 SCAF1 CACTIN SRSF11 PRPF38A SRSF2 RSRC2 SRSF6 LUC7L3 RNPS1 SON ZRANB2 | 1.76e-08 | 1158 | 42 | 13 | MM1338 |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 4.35e-08 | 212 | 42 | 7 | MM3816 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 3.69e-07 | 432 | 42 | 8 | M41149 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 7.77e-07 | 656 | 42 | 9 | M18979 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | SNRNP27 SRSF11 PPIG SREK1 SRSF2 RSRC2 SRSF5 SRSF6 LUC7L3 STK35 RNPS1 | 7.85e-07 | 1088 | 42 | 11 | MM3699 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 8.33e-07 | 203 | 42 | 6 | MM3795 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | SNRNP27 SRRM1 RSRP1 ZFYVE26 SRSF11 PPIG SRSF2 SRSF6 AKAP17A CLK2 CDK13 SRSF8 | 1.22e-06 | 1394 | 42 | 12 | M9585 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 2.86e-06 | 568 | 42 | 8 | M4023 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 4.94e-06 | 822 | 42 | 9 | M6782 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | 4.94e-06 | 612 | 42 | 8 | MM3804 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 6.40e-06 | 634 | 42 | 8 | M40866 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 6.75e-06 | 166 | 42 | 5 | M8129 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 1.07e-05 | 680 | 42 | 8 | M41089 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | 1.07e-05 | 905 | 42 | 9 | M40865 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 1.56e-05 | 338 | 42 | 6 | M17094 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP | 1.59e-05 | 198 | 42 | 5 | M5018 | |
| Coexpression | GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN | 1.62e-05 | 199 | 42 | 5 | M8571 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 1.62e-05 | 199 | 42 | 5 | M7607 | |
| Coexpression | GSE27786_BCELL_VS_NEUTROPHIL_UP | 1.66e-05 | 200 | 42 | 5 | M4813 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.70e-05 | 519 | 42 | 7 | M3395 | |
| Coexpression | BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN | 2.02e-05 | 33 | 42 | 3 | M8981 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 2.27e-05 | 543 | 42 | 7 | MM997 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.69e-05 | 221 | 42 | 5 | M39222 | |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 2.81e-05 | 223 | 42 | 5 | M17621 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | 6.68e-05 | 644 | 42 | 7 | M41717 | |
| Coexpression | GARY_CD5_TARGETS_DN | 6.80e-05 | 440 | 42 | 6 | M13893 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN | 6.85e-05 | 137 | 42 | 4 | M4781 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CLASSICAL_MONOCYTE_AGEING | 6.89e-05 | 441 | 42 | 6 | MM3765 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | 9.55e-05 | 1492 | 42 | 10 | M40023 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 1.02e-04 | 474 | 42 | 6 | M40991 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 1.07e-04 | 1215 | 42 | 9 | M41122 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 1.34e-04 | 720 | 42 | 7 | MM3700 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 1.50e-04 | 318 | 42 | 5 | M41707 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 2.14e-04 | 184 | 42 | 4 | M19988 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 2.23e-04 | 186 | 42 | 4 | M4911 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 2.34e-04 | 1055 | 42 | 8 | MM3677 | |
| Coexpression | GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP | 2.51e-04 | 192 | 42 | 4 | M7558 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 2.72e-04 | 196 | 42 | 4 | M4928 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 2.77e-04 | 363 | 42 | 5 | M41103 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_BASAL | 2.78e-04 | 79 | 42 | 3 | M39048 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 2.78e-04 | 79 | 42 | 3 | M7102 | |
| Coexpression | FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL | 2.84e-04 | 365 | 42 | 5 | M41711 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN | 2.88e-04 | 199 | 42 | 4 | M3716 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 2.88e-04 | 199 | 42 | 4 | M7254 | |
| Coexpression | GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP | 2.88e-04 | 199 | 42 | 4 | M3262 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN | 2.88e-04 | 199 | 42 | 4 | M8313 | |
| Coexpression | GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 2.88e-04 | 199 | 42 | 4 | M4460 | |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 2.88e-04 | 199 | 42 | 4 | M7549 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_1H_BMDC_DN | 2.88e-04 | 199 | 42 | 4 | M3800 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 2.93e-04 | 200 | 42 | 4 | M9472 | |
| Coexpression | GSE17721_CTRL_VS_CPG_8H_BMDC_DN | 2.93e-04 | 200 | 42 | 4 | M3768 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN | 2.93e-04 | 200 | 42 | 4 | M7134 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 2.93e-04 | 200 | 42 | 4 | M8306 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 2.93e-04 | 200 | 42 | 4 | M6653 | |
| Coexpression | GSE11924_TFH_VS_TH2_CD4_TCELL_UP | 2.93e-04 | 200 | 42 | 4 | M3153 | |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP | 2.93e-04 | 200 | 42 | 4 | M4884 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_12H_BMDC_DN | 2.93e-04 | 200 | 42 | 4 | M3817 | |
| Coexpression | LEE_METASTASIS_AND_RNA_PROCESSING_UP | 2.97e-04 | 16 | 42 | 2 | M8887 | |
| Coexpression | LEE_DIFFERENTIATING_T_LYMPHOCYTE | 2.99e-04 | 201 | 42 | 4 | M2200 | |
| Coexpression | LAIHO_COLORECTAL_CANCER_SERRATED_DN | 3.45e-04 | 85 | 42 | 3 | M17423 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_DN | 3.59e-04 | 211 | 42 | 4 | M1866 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_DN | 4.00e-04 | 217 | 42 | 4 | MM778 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_B_CELL_AGEING | 5.06e-04 | 231 | 42 | 4 | MM3741 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_INTERMEDIATE_MONOCYTE_AGEING | 5.33e-04 | 419 | 42 | 5 | MM3768 | |
| Coexpression | AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN | 5.57e-04 | 237 | 42 | 4 | M8897 | |
| Coexpression | TABULA_MURIS_SENIS_SKIN_BULGE_KERATINOCYTE_AGEING | 5.73e-04 | 915 | 42 | 7 | MM3828 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 5.93e-04 | 429 | 42 | 5 | M29 | |
| Coexpression | XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN | 6.21e-04 | 23 | 42 | 2 | M18912 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_UP | 6.99e-04 | 445 | 42 | 5 | M7928 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | 7.45e-04 | 687 | 42 | 6 | M41022 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP | 7.92e-04 | 113 | 42 | 3 | M1260 | |
| Coexpression | BENPORATH_NANOG_TARGETS | 9.01e-04 | 988 | 42 | 7 | M6616 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 9.31e-04 | 272 | 42 | 4 | MM3825 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 1.05e-03 | 734 | 42 | 6 | M3835 | |
| Coexpression | TBK1.DF_DN | 1.12e-03 | 286 | 42 | 4 | M2864 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_NK_CELL_AGEING | 1.15e-03 | 288 | 42 | 4 | MM3751 | |
| Coexpression | CAFFAREL_RESPONSE_TO_THC_UP | 1.21e-03 | 32 | 42 | 2 | M11298 | |
| Coexpression | DORSAM_HOXA9_TARGETS_UP | 1.44e-03 | 35 | 42 | 2 | M10445 | |
| Coexpression | PECE_MAMMARY_STEM_CELL_DN | 1.59e-03 | 144 | 42 | 3 | M2535 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.01e-06 | 564 | 41 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.58e-06 | 595 | 41 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.49e-06 | 629 | 41 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.81e-06 | 249 | 41 | 6 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.77e-06 | 259 | 41 | 6 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 1.00e-05 | 150 | 41 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.04e-05 | 151 | 41 | 5 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 1.08e-05 | 403 | 41 | 7 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.37e-05 | 275 | 41 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.75e-05 | 801 | 41 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SRRM1 SRSF11 PRPF38B PPIG SREK1 RSRC2 LUC7L3 PNISR CLK2 RSRC1 DHX8 | 1.82e-05 | 1257 | 41 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 1.84e-05 | 806 | 41 | 9 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.22e-05 | 498 | 41 | 7 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SRRM1 SRSF11 PRPF38B PPIG SREK1 RSRC2 LUC7L3 PNISR CLK2 RSRC1 DHX8 | 7.18e-05 | 1459 | 41 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.78e-05 | 230 | 41 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.12e-05 | 378 | 41 | 6 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.03e-04 | 395 | 41 | 6 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.14e-04 | 790 | 41 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 1.21e-04 | 797 | 41 | 8 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_100 | 1.23e-04 | 50 | 41 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 1.23e-04 | 799 | 41 | 8 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.32e-04 | 413 | 41 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 1.36e-04 | 136 | 41 | 4 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 1.46e-04 | 819 | 41 | 8 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.62e-04 | 429 | 41 | 6 | gudmap_developingGonad_e14.5_ testes_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 1.78e-04 | 843 | 41 | 8 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.86e-04 | 277 | 41 | 5 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.99e-04 | 281 | 41 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 2.22e-04 | 61 | 41 | 3 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 2.69e-04 | 65 | 41 | 3 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.17e-04 | 311 | 41 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 3.33e-04 | 172 | 41 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.78e-04 | 323 | 41 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.74e-04 | 524 | 41 | 6 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 4.95e-04 | 1241 | 41 | 9 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.18e-04 | 533 | 41 | 6 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 5.22e-04 | 989 | 41 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 6.23e-04 | 203 | 41 | 4 | gudmap_developingGonad_e11.5_testes_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.34e-04 | 362 | 41 | 5 | gudmap_developingGonad_e18.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 6.54e-04 | 778 | 41 | 7 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_100 | 6.99e-04 | 90 | 41 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.07e-04 | 210 | 41 | 4 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 7.43e-04 | 795 | 41 | 7 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 7.94e-04 | 804 | 41 | 7 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 8.69e-04 | 97 | 41 | 3 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.14e-04 | 225 | 41 | 4 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_100 | 9.21e-04 | 99 | 41 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.01e-03 | 231 | 41 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 1.05e-03 | 844 | 41 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.06e-03 | 406 | 41 | 5 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | 1.06e-03 | 406 | 41 | 5 | gudmap_developingGonad_e12.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 1.10e-03 | 409 | 41 | 5 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 1.15e-03 | 107 | 41 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500 | 1.18e-03 | 241 | 41 | 4 | gudmap_developingGonad_e12.5_testes_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.19e-03 | 417 | 41 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 1.22e-03 | 109 | 41 | 3 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.44e-03 | 435 | 41 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | 1.47e-03 | 437 | 41 | 5 | gudmap_developingGonad_e11.5_testes_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.53e-03 | 118 | 41 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | 1.64e-03 | 1468 | 41 | 9 | facebase_RNAseq_e10.5_MandArch_2500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_100 | 1.74e-03 | 32 | 41 | 2 | gudmap_developingGonad_e18.5_epididymis_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.15e-03 | 284 | 41 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#1_top-relative-expression-ranked_500 | 2.49e-03 | 140 | 41 | 3 | gudmap_developingGonad_e18.5_testes_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_200 | 2.71e-03 | 40 | 41 | 2 | gudmap_developingGonad_P2_epididymis_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 3.14e-03 | 152 | 41 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | 3.39e-03 | 770 | 41 | 6 | gudmap_developingGonad_P2_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 3.53e-03 | 776 | 41 | 6 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200 | 3.56e-03 | 159 | 41 | 3 | gudmap_developingGonad_e12.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_500 | 3.57e-03 | 46 | 41 | 2 | gudmap_developingGonad_e12.5_epididymis_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 3.69e-03 | 161 | 41 | 3 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 3.69e-03 | 161 | 41 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.72e-03 | 47 | 41 | 2 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 3.76e-03 | 162 | 41 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_100 | 3.88e-03 | 48 | 41 | 2 | gudmap_developingGonad_e14.5_ epididymis_100_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_200 | 3.95e-03 | 165 | 41 | 3 | gudmap_developingGonad_e12.5_testes_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.02e-03 | 166 | 41 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 4.02e-03 | 166 | 41 | 3 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 4.04e-03 | 49 | 41 | 2 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 4.09e-03 | 167 | 41 | 3 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#1_top-relative-expression-ranked_500 | 4.09e-03 | 167 | 41 | 3 | gudmap_developingGonad_e16.5_testes_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 4.48e-03 | 815 | 41 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | 4.59e-03 | 819 | 41 | 6 | gudmap_developingGonad_e16.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | 4.67e-03 | 822 | 41 | 6 | gudmap_developingGonad_e14.5_ testes_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#5 | 4.71e-03 | 53 | 41 | 2 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_200 | 4.96e-03 | 179 | 41 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_200 | 5.12e-03 | 181 | 41 | 3 | gudmap_developingGonad_e11.5_testes_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#4_top-relative-expression-ranked_500 | 5.36e-03 | 184 | 41 | 3 | gudmap_developingGonad_e14.5_ testes_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 5.52e-03 | 186 | 41 | 3 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.38e-03 | 196 | 41 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 6.46e-03 | 387 | 41 | 4 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_200 | 6.80e-03 | 64 | 41 | 2 | gudmap_developingGonad_e16.5_ovary_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_200 | 6.80e-03 | 64 | 41 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 6.94e-03 | 395 | 41 | 4 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 7.01e-03 | 65 | 41 | 2 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 7.22e-03 | 205 | 41 | 3 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 7.50e-03 | 404 | 41 | 4 | gudmap_developingGonad_e18.5_epididymis_500 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | RSRP1 SRSF11 PRPF38B SREK1 SRSF2 LUC7L3 SRRM2 PNISR CCNL1 SON | 2.07e-15 | 192 | 42 | 10 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.12e-15 | 200 | 42 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-13 | 188 | 42 | 9 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.94e-13 | 197 | 42 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.32e-11 | 199 | 42 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.57e-10 | 197 | 42 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 7.05e-10 | 199 | 42 | 7 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.23e-09 | 147 | 42 | 6 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 166 | 42 | 6 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-08 | 187 | 42 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.66e-08 | 193 | 42 | 6 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-08 | 194 | 42 | 6 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-08 | 194 | 42 | 6 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.91e-08 | 196 | 42 | 6 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.00e-08 | 197 | 42 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 3.00e-08 | 197 | 42 | 6 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.10e-08 | 198 | 42 | 6 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-08 | 198 | 42 | 6 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 3.19e-08 | 199 | 42 | 6 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.29e-08 | 200 | 42 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-07 | 182 | 42 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.83e-07 | 187 | 42 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.30e-07 | 189 | 42 | 5 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.30e-07 | 189 | 42 | 5 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-immature_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-07 | 190 | 42 | 5 | a550806f015d26f809df51a9af04541f2d16a2fc | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.01e-06 | 192 | 42 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 192 | 42 | 5 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 194 | 42 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 1.11e-06 | 196 | 42 | 5 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | Healthy_donor|World / disease group, cell group and cell class (v2) | 1.17e-06 | 198 | 42 | 5 | 1ed0b50c9754727a05c27b21f3546bf2e37eef7f | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-06 | 198 | 42 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.17e-06 | 198 | 42 | 5 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-06 | 198 | 42 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 1.17e-06 | 198 | 42 | 5 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 199 | 42 | 5 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.23e-06 | 200 | 42 | 5 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.23e-06 | 200 | 42 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.94e-06 | 135 | 42 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 178 | 42 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 185 | 42 | 4 | 7acc071ea75442817db4d98bd3ed3fff6f0a9d46 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.04e-05 | 190 | 42 | 4 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 191 | 42 | 4 | 4bd9db45e7b5c0d04368e08c8199d390744aa317 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 191 | 42 | 4 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-05 | 191 | 42 | 4 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 192 | 42 | 4 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.17e-05 | 192 | 42 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 192 | 42 | 4 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.23e-05 | 193 | 42 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.23e-05 | 193 | 42 | 4 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.23e-05 | 193 | 42 | 4 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 3.30e-05 | 194 | 42 | 4 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.37e-05 | 195 | 42 | 4 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.37e-05 | 195 | 42 | 4 | dc84a910b6f6eb9994cd683aa4fd813a82198e5f | |
| ToppCell | droplet-Tongue-TONGUE|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 196 | 42 | 4 | 44a30b1a5f3d8c845e5f3bd17d8102a7449f555b | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 196 | 42 | 4 | a85f5f1e6acc798e9e02b1a21e0ffe87a323c333 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-05 | 196 | 42 | 4 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | 3'|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-05 | 196 | 42 | 4 | 44007f0c14e0f0703f7ee715b8eababb4d80a8b5 | |
| ToppCell | droplet-Tongue-TONGUE-1m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 196 | 42 | 4 | 9935bdb10789e8cfc922dca526ca3bf8317fe270 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 3.50e-05 | 197 | 42 | 4 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.50e-05 | 197 | 42 | 4 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.57e-05 | 198 | 42 | 4 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.57e-05 | 198 | 42 | 4 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.64e-05 | 199 | 42 | 4 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.64e-05 | 199 | 42 | 4 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 3.72e-05 | 200 | 42 | 4 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 3.86e-04 | 151 | 42 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.83e-04 | 163 | 42 | 3 | 99cf60dc87f7ce288553091bffcd85109a02bd8f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.83e-04 | 163 | 42 | 3 | 510c0af66e82c5a8cf8edd0547dae4018a87dbbf | |
| ToppCell | P15|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.55e-04 | 171 | 42 | 3 | 155e7abd52b84d16146001f6ca49ca0c2294a823 | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.55e-04 | 171 | 42 | 3 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | 3'_v3-lymph-node_spleen|World / Manually curated celltypes from each tissue | 5.55e-04 | 171 | 42 | 3 | 7aae88da5b37c20f10118325a048f08906be994c | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 178 | 42 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-04 | 180 | 42 | 3 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | droplet-Marrow-BM|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-04 | 181 | 42 | 3 | 4169a1527b9c8f5783b8cc44e3a3924f8ed9a5e2 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-04 | 183 | 42 | 3 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-04 | 183 | 42 | 3 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-04 | 184 | 42 | 3 | bb416c96ea5edfa46819fe79888b223d09278943 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-04 | 184 | 42 | 3 | 46e77d879d6f8f779a00c5683611ec9b9e8acc53 | |
| ToppCell | PBMC-Mild-cDC_8|Mild / Compartment, Disease Groups and Clusters | 6.98e-04 | 185 | 42 | 3 | 891b39c20fe9858fbba90d9ef7a253f1a0870211 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-|lymph-node_spleen / Manually curated celltypes from each tissue | 7.20e-04 | 187 | 42 | 3 | 9000241566f48e435db9409b7255db68b68f6059 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.31e-04 | 188 | 42 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.31e-04 | 188 | 42 | 3 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.31e-04 | 188 | 42 | 3 | 2156f1bc849ff1cb09ae296d13bedd913ae6b43b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-04 | 189 | 42 | 3 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | metastatic_Brain-T/NK_cells-NK|metastatic_Brain / Location, Cell class and cell subclass | 7.54e-04 | 190 | 42 | 3 | 50e937ba0600e1ac6215f056bb545dc1e8b28a76 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.65e-04 | 191 | 42 | 3 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | PBMC-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 7.77e-04 | 192 | 42 | 3 | 385061d6257295bd515dea98f9bcd52374509276 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-04 | 192 | 42 | 3 | 7299a0bbba8998cff4c6fd136f7e2d644ee5bd45 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-immature_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-04 | 192 | 42 | 3 | 7ad0aa18d6debe0dc26dbb0d33be656b734b5e73 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.89e-04 | 193 | 42 | 3 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 193 | 42 | 3 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 193 | 42 | 3 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 193 | 42 | 3 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | Control-B_naive-13|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.89e-04 | 193 | 42 | 3 | 32e53a6473a682cf14b20a399c3686f658298b93 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.01e-04 | 194 | 42 | 3 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 8.01e-04 | 194 | 42 | 3 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-04 | 194 | 42 | 3 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.01e-04 | 194 | 42 | 3 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.01e-04 | 194 | 42 | 3 | 5022c85ad3b137dae4b9ff11f9c23bb3bf4c0f5a | |
| ToppCell | facs-Skin-Skin_Anagen-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 195 | 42 | 3 | 0d37dd66a8d60fc9cda3d6e3c4fbe67e577b890e | |
| Computational | Neighborhood of DDX5 | 2.09e-08 | 63 | 31 | 6 | GNF2_DDX5 | |
| Computational | RNA splicing. | 1.04e-06 | 65 | 31 | 5 | MODULE_183 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.66e-04 | 49 | 31 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.88e-04 | 50 | 31 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Neighborhood of CDC10 | 7.73e-04 | 146 | 31 | 4 | MORF_CDC10 | |
| Computational | Genes in the cancer module 98. | 7.78e-04 | 393 | 31 | 6 | MODULE_98 | |
| Drug | AC1NRA5C | SREK1 SRSF2 SRSF5 SRSF6 AKAP17A SRRM2 RNPS1 CDK13 CCNL1 ZRANB2 | 6.24e-13 | 174 | 42 | 10 | CID005287709 |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.13e-07 | 172 | 42 | 6 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.16e-07 | 176 | 42 | 6 | 6932_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 9.01e-07 | 179 | 42 | 6 | 4585_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.16e-06 | 187 | 42 | 6 | 4302_DN | |
| Drug | ((5Z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4H-imidazol-4-one) | 1.27e-06 | 12 | 42 | 3 | ctd:C578491 | |
| Drug | resorcinol | 1.57e-06 | 197 | 42 | 6 | ctd:C031389 | |
| Drug | 5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA | 1.62e-06 | 198 | 42 | 6 | 950_DN | |
| Drug | PCI 5002 | 6.22e-06 | 735 | 42 | 9 | ctd:C568608 | |
| Drug | benz(a)anthracene | ACIN1 SRSF11 PRPF38B PPIG SRSF5 LUC7L3 SRRM2 PNISR STK35 CLK2 CCNL1 | 1.17e-05 | 1251 | 42 | 11 | ctd:C030935 |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.49e-05 | 170 | 42 | 5 | 1050_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.86e-05 | 178 | 42 | 5 | 5086_DN | |
| Drug | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol | 2.27e-05 | 314 | 42 | 6 | ctd:C572491 | |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 2.36e-05 | 187 | 42 | 5 | 3075_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A | 3.17e-05 | 199 | 42 | 5 | 122_DN | |
| Drug | 1,12-benzoperylene | 6.45e-05 | 231 | 42 | 5 | ctd:C006718 | |
| Drug | hexaconazole | 6.81e-05 | 119 | 42 | 4 | ctd:C409722 | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 1.42e-05 | 33 | 42 | 3 | DOID:4467 (is_marker_for) | |
| Disease | syndrome (implicated_via_orthology) | 2.98e-04 | 18 | 42 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | colon adenocarcinoma (is_marker_for) | 5.81e-04 | 25 | 42 | 2 | DOID:234 (is_marker_for) | |
| Disease | congestive heart failure (is_implicated_in) | 6.79e-04 | 27 | 42 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | eotaxin measurement | 5.83e-03 | 80 | 42 | 2 | EFO_0008122 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRSRSPRRRSRSPRR | 456 | Q13523 | |
| RSPRRRDRGRRSRSR | 466 | Q13523 | |
| REGPRSRSRSRDRRR | 1171 | Q9UKV3 | |
| RDRRDTKRHSRSRSR | 1316 | Q9UKV3 | |
| FSRRSLRRARPRRSH | 31 | Q15173 | |
| RKHRRRRRRSRTFSR | 116 | P49760 | |
| FLSRRRRARSSVCRR | 356 | P18825 | |
| RSRHRRRSRERGPYR | 236 | P49761 | |
| RSRTRSRSRSHTPRR | 396 | Q9UK58 | |
| RSRSRHRLSRSRSRH | 421 | Q14004 | |
| ERRKLSRSRSRDRHR | 286 | Q9NQ29 | |
| SRSRSRDRHRRHRSR | 291 | Q9NQ29 | |
| DRERRKRSRSRSRHS | 286 | O95232 | |
| RRCSRSRDHKRSRSR | 306 | O95232 | |
| SRDHKRSRSRERRRS | 311 | O95232 | |
| RSRDRRRSRSHDRSE | 326 | O95232 | |
| RHRSRDRRRGGSRSR | 46 | Q9BUQ8 | |
| SRSRDRSRRVRSRTH | 566 | Q13427 | |
| RSRRVRSRTHDRDRS | 571 | Q13427 | |
| RDDNRRFRPHRSRRS | 676 | Q7Z3G6 | |
| RFRPHRSRRSRRSRS | 681 | Q7Z3G6 | |
| RSRSRSHGRRNRRRR | 26 | Q8WUQ7 | |
| RRSRSGSRSRRSRHR | 446 | O95104 | |
| GSRSRRSRHRRSRSR | 451 | O95104 | |
| RSRHRRSRSRSRDRR | 456 | O95104 | |
| RSRSRSRDRRRHSPR | 461 | O95104 | |
| RTHSRSRSRSPRKRR | 401 | Q9UPN6 | |
| RDHKRRHRSRSRSRS | 196 | Q14562 | |
| RHRSRSRSRSRTRER | 201 | Q14562 | |
| RGRSHSRSRSRERRH | 121 | Q7L4I2 | |
| SRSRSRERRHRSRSR | 126 | Q7L4I2 | |
| IRSRSRSRSRHRHRT | 176 | Q7L4I2 | |
| RSRSRHRHRTRSRSR | 181 | Q7L4I2 | |
| RSRSRSRSPRRRAHS | 801 | Q12872 | |
| SRSPRRRAHSPERRR | 806 | Q12872 | |
| GRRSRSPRRRRRSRS | 116 | Q01130 | |
| SPRRRRRSRSRSRSR | 121 | Q01130 | |
| RDRSDSGSRRKRRHR | 211 | A6NNA2 | |
| RRRRRSRSSASAPRR | 391 | A6NNA2 | |
| PSRRRHDNRRRSRSK | 126 | Q15287 | |
| RRRSRSPRRRSPVRR | 271 | Q15287 | |
| RSRSPGRRRHRSRSS | 286 | Q15287 | |
| RRRSRSRTPTRRRSR | 591 | Q9UQ35 | |
| ARRRSRTRSPVRRRS | 621 | Q9UQ35 | |
| SRRRSRSRTSVTRRR | 1896 | Q9UQ35 | |
| RDRRRSRSRSPHRRR | 36 | Q8WVK2 | |
| SRSRSPHRRRSRSPR | 41 | Q8WVK2 | |
| PHRRRSRSPRRHRST | 46 | Q8WVK2 | |
| RRRRRSRSSSRSPRT | 381 | Q8WXA9 | |
| SRSRSRRRSRSRSRR | 196 | Q13247 | |
| RRRSRSRSRRSSRSR | 201 | Q13247 | |
| YGRRSRSPRRRHRSR | 121 | Q9BRL6 | |
| KRHSRSRSRSRSRTR | 181 | Q13243 | |
| RSRRSKSRSRSRRRH | 56 | Q9BUV0 | |
| HSRWRDRSRTRSRSR | 151 | Q9BUV0 | |
| HSRHRRRSERSRSRS | 671 | Q02040 | |
| RRSERSRSRSPSRHR | 676 | Q02040 | |
| RRARAATSRAARSRR | 56 | Q8TDR2 | |
| RRHSRSRSRSRRRRT | 246 | Q05519 | |
| RRRRTPSSSRHRRSR | 256 | Q05519 | |
| PSSSRHRRSRSRSRR | 261 | Q05519 | |
| HRRSRSRSRRRSHSK | 266 | Q05519 | |
| SRSRRRSHSKSRSRR | 271 | Q05519 | |
| RSKSPRRRRSHSRER | 286 | Q05519 | |
| RRRRSHSRERGRRSR | 291 | Q05519 | |
| STARRSRSASRERRR | 331 | Q05519 | |
| RRRSRSRSRSRSTRR | 571 | Q9H7N4 | |
| RSTRRRSRSTDRRRG | 581 | Q9H7N4 | |
| RSPSHTRPRRRHRSR | 291 | Q8IYB3 | |
| PRHRRSRSPVRRRRR | 336 | Q8IYB3 | |
| ERRRSRSRERHRSRS | 326 | Q5VTL8 | |
| RSRERHRSRSRSRDR | 331 | Q5VTL8 | |
| HRSRSRSRDRKGDRR | 336 | Q5VTL8 | |
| SRSRSRERKHRSRSR | 426 | Q5VTL8 | |
| ARSRSPDHRRTRARA | 211 | Q9NVW2 | |
| RSRSRSRSRRRSRTR | 551 | A7MD48 | |
| KSPRRHRSRSRDRRH | 261 | Q8NAV1 | |
| HRSRSRDRRHRSRSK | 266 | Q8NAV1 | |
| RRSRSRPRLRSHSRS | 106 | Q96IZ7 | |
| RRTRSRSPERRHRSS | 301 | O95218 | |
| RRRNRSPSRERRRSR | 606 | Q8TF01 | |
| SPSRERRRSRSRSRD | 611 | Q8TF01 | |
| TRHPSLRRGRRTRRS | 761 | Q68DK2 | |
| SHRSQTRSRSRSRRR | 1856 | P18583 | |
| TRSRSRSRRRRRSSR | 1861 | P18583 | |
| SRRSRSHTPSRRRRS | 1926 | P18583 | |
| RLRRSRTPLRRRFSR | 2016 | P18583 |